Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Clinical trial NCT00045968 · UNKNOWN

Trial details

NCT number: NCT00045968
Sponsor: Northwest Biotherapeutics
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Glioblastoma Multiforme Glioblastoma GBM Grade IV Astrocytoma Glioma Brain Cancer Brain Tumor

Start date: 2006-12-01
Primary completion: 2022-11-01
Enrollment: 348

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.